Ronald S. Duman,
John H. Krystal
Rapid Acting Antidepressants
Gebonden Engels 2020 9780128201893Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.
Specificaties
ISBN13:9780128201893
Taal:Engels
Bindwijze:Gebonden
Aantal pagina's:402
Uitgever:Elsevier Science
Serie:Advances in Pharmacology
Thema:
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Inhoudsopgave
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission Allie J. Widman and Lori L. McMahon
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson
- The role of eEF2 kinase in the rapid antidepressant actions of ketamine Kanzo Suzuki and Lisa M. Monteggia Part II – The rapid therapeutic effects of ketamine
- Clinical overview of NMDA-R antagonists and clinical practice Pasha A. Davoudian and Samuel T. Wilkinson
- Ketamine for depression clinical issues Syed Z. Iqbal and Sanjay J. Mathew
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
- Neurobiological biomarkers of response to ketamine Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
- The emergence of ketamine as a novel treatment for posttraumatic stress disorder Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney Part III – Novel rapid-acting antidepressant mechanisms related to ketamine
- mGlu2/3 receptor as a novel target for rapid acting antidepressants Shigeyuki Chaki
- Involvement of muscarinic receptor mechanisms in antidepressant drug action Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions
Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan